Skip to main content
uniQure N.V. logo

uniQure N.V. — Investor Relations & Filings

Ticker · QURE ISIN · NL0010696654 LEI · 724500RPCTZLFYJZ3S98 US Manufacturing
Filings indexed 859 across all filing types
Latest filing 2015-08-10 Major Shareholding Noti…
Country NL Netherlands
Listing US QURE

About uniQure N.V.

https://www.uniqure.com/

uniQure N.V. is a gene therapy company focused on developing and commercializing treatments for patients with rare and severe diseases. The company utilizes its adeno-associated virus (AAV) based technology platform to create single-administration therapies with the potential for curative results. Its research and development pipeline is concentrated on liver-directed and central nervous system (CNS) disorders, with a key clinical program targeting Huntington's disease. uniQure aims to deliver transformative medicines by translating scientific innovation into viable treatments.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2015
Major Shareholding Notification
2015-08-10 English
6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, uniQure N.V., with the SEC. It includes a press release announcing unaudited financial results for the first quarter ended March 31, 2015, and the unaudited financial statements for that quarter. The presence of unaudited financial statements for a quarter indicates this is an interim or quarterly report. The document length is 2382 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2015-06-11 English
6-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 6-K filed by a foreign private issuer, uniQure N.V., with the SEC. It reports the results of the 2015 Annual General Meeting (AGM) held on June 10, 2015. The content includes detailed voting results on various agenda items such as adoption of the annual report and accounts for 2014, discharge of liability for the Management and Supervisory Boards, appointment of auditors and board members, remuneration, share issuance authorizations, and share repurchase authorizations. The document is focused on the official announcement of voting results from the AGM rather than the full annual report or other detailed financial disclosures. The length of the document (6171 characters) and the nature of the content align with a Declaration of Voting Results & Voting Rights Announcements filing. Therefore, the appropriate classification is DVA (Declaration of Voting Results & Voting Rights Announcements).
2015-06-11 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, uniQure N.V., with the SEC. It includes a press release announcing the closing of a collaboration and license agreement with Bristol-Myers Squibb Company. The document is short (2173 characters) and primarily serves as an announcement of a business collaboration, not a detailed financial report or earnings release. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2015-05-26 English
6-K
Report Publication Announcement Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, uniQure N.V., with the SEC. It states that Exhibit 99.1 is the Dutch statutory annual report for the year ended December 31, 2014, which was made available to shareholders around May 6, 2015. The document itself is only 2150 characters long and primarily serves to furnish the annual report as an exhibit rather than containing the full annual report text. According to the 'Menu vs Meal' rule, since this document is short and indicates the report is attached or made available, it should be classified as a Report Publication Announcement (RPA) rather than the Annual Report (10-K) itself.
2015-05-11 English
6-K
AGM Information Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, uniQure N.V., with the SEC. It includes a Notice, Agenda, and Explanatory Notes for the 2015 Annual General Meeting of Shareholders. The content focuses on materials related to the AGM rather than the AGM results or voting outcomes. The document length is short (2068 characters), and it is not a full report but rather materials shared for the AGM. Therefore, it fits the category of AGM Information (AGM-R).
2015-05-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.